UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 12 | Issue 11 | November 2025

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 12 Issue 11
November-2025
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2511184


Registration ID:
571398

Page Number

b675-b680

Share This Article


Jetir RMS

Title

Pharmacological and Therapeutic Potential of Terminalia Arjuna (Roxb.) wight & Arn: A Review

Abstract

Terminalia arjuna (Roxb.) Wight & Arn., belonging to the family Combretaceae, is a medicinal plant widely recognized in traditional Indian medicine for its broad spectrum of therapeutic properties. The bark, rich in bioactive constituents such as triterpenoids, flavonoids, glycosides, and tannins, has been extensively used for its cardiotonic, antioxidant, anti-inflammatory, antimicrobial, and wound healing properties. Arjunolic acid, arjunin, arjun sides, and gallic acid are among the phytochemical compounds that contribute to its pharmacological properties. It has been found to be effective in diabetes management, hypolipidemic effects, antitumor activity, cardiovascular protection,and antitumor activity. Modern pharmacological evaluations have confirmed its efficacy in cardio protection, antitumor activity, hypolipidemic effects, and diabetes management. This review highlights the traditional uses, phytochemistry, and pharmacological significance of T. arjuna, supporting its potential as a valuable source of natural therapeutic agents.

Key Words

Terminalia Arjuna pharmacological actions, Anti-oxidant and Anti-bacterial Anti-microbial, Anti-tumour, Wound healing, Cardioprotective, Anti-inflammatory, Anti-diabetic, Anti-lipidemic, Anti-asthmatic.

Cite This Article

"Pharmacological and Therapeutic Potential of Terminalia Arjuna (Roxb.) wight & Arn: A Review", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.12, Issue 11, page no.b675-b680, November-2025, Available :http://www.jetir.org/papers/JETIR2511184.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Pharmacological and Therapeutic Potential of Terminalia Arjuna (Roxb.) wight & Arn: A Review", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.12, Issue 11, page no. ppb675-b680, November-2025, Available at : http://www.jetir.org/papers/JETIR2511184.pdf

Publication Details

Published Paper ID: JETIR2511184
Registration ID: 571398
Published In: Volume 12 | Issue 11 | Year November-2025
DOI (Digital Object Identifier):
Page No: b675-b680
Country: Nashik, Maharashtra, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

00040

Print This Page

Current Call For Paper

Jetir RMS